Abstract

Purpose of the study: In vitro to study the degree of adhesion of vitreous substitutes, such as silicone oil of various viscosities and perfluorodecalin (PFOS), to hydrophobic acrylic polymer IOLs and evaluate the interaction of vitreous substitutes with the model MIOL-Soft-23 in the clinic. Material and methods. IOLs of the model MIOL-Soft-23 were taken for the experiment. MIOL-Soft-23 are included in the RPR-20 set. IOL of the model MIOL-Soft-23 is made by photopolymerization from a biocompatible spatially cross-linked hydrophobic acrylic polymer based on oligomers and monomers of the methacrylic series with filters in the ultraviolet region of the spectrum from 19 to 23 D. For the experiment, silicone oils of different viscosities were taken: RS-OIL 2000 (Alchimia), SIL-5000-S (DORC), Oxane 5700 (Bausch & Lomb), PFOS (perfluorodecalin) Dk-line (Bausch & Lomb). Also, saline sodium chloride 0.9 % (Solofarm) was used. Results. Revealed a decrease in the degree of silicone adhesion to the surface of acrylic hydrophobic IOLs as the temperature rises, not less than 1.5 %. The absence of dependence of the degree of adhesion on the degree of viscosity of silicone oil was confirmed, which corresponds to the literature data. For the first time, the average percentage of adhesion of perfluorodecalin to the IOL surface data were obtained, in particular, the MIOL-Soft-23 model. The range of values ranged from 0.7 to 7.2 %. The average coverage percentage is 1.9 ± 1.3 % (exposure at 37 ± 1 °C for up to 14 days) and 3.4 ± 1.5 % (exposure at room temperature for up to 14 days). This confirms the need for careful intraoperative monitoring of the completeness of removal of PFOS droplets from the IOL surface. Conclusion. The presence of the risk of adhesion of residual drops of silicone oil and PFOS to the surface of the IOL necessitates careful intraoperative control of the completeness of the removal of vitreous body substitutes, as well as further search for the best ways to eliminate this complication. The conducted complex of studies makes it possible to recommend the use of IOL model MIOL-Soft-23 in complicated cases of vitreal surgery.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.